Averaged BP for each month consisting of 8 sessions was stable until the endpoint in control group. In the YKSCH group, averaged BP increased at 6 months of age and lasted. 
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, a multicenter longitudinal cohort study. Subjects aged over 65 years, diagnosed with AD, SVD, or FTD at baseline were selected. NPS were grouped into 4 clusters: the psychosis cluster (delusions and hallucinations), the hyperactivity cluster (agitation/aggression, disinhibition, and irritability/lability), the affect cluster (depression and anxiety), and the apathy cluster (apathy/indifference, sleep/night-time disturbances, and appetite/eating abnormalities). Kaplan-Meier plots, log-rank tests and time dependent Cox proportional hazard models were utilized with adjusting various covariates. Results: 4,410 cases of AD, 829 cases of SVD, and 129 cases of FTD were selected, with 851, 248, and 26 individuals currently deceased from each respective group. The presence of the psychosis cluster symptom (p < .05; mild symptom: HR = 1.23, 95% CI 0.83-1.82; clinically significant symptom: HR = 1.89, 95% CI 1.24-2.86) at baseline was a risk factor for mortality in SVD. In FTD, the presence of the affect cluster symptom (p < .05; mild symptom: HR = 9.89, 95% CI 1.93-50.60; clinically significant symptom: HR = 4.92, 95% CI 0.62-39.27) at baseline was significantly associated with mortality. None of the clusters were associated with mortality in AD group. Conclusions: These findings demonstrate that NPS may increase the risk of mortality in subjects with dementia, and that its effects may differ according to dementia subtype. This indicates that the screening and intervention of NPS may be an important preventive strategy to delay progression to death, and that symptoms should be considered differently with regard to dementia subtype.
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Body Mass Index and Progression to Dementia in Patients with Mild Cognitive Impairment
Soo Hyun Joo, Chang Uk Lee
Abstract Introduction: Obesity has been proposed to lead to dementia. However, recent research found that being underweight also could increase the risk of dementia. We investigated the influence of body mass index (BMI) status at baseline on the development of dementia in mild cognitive impairment (MCI) patients. Methods: For this study, we used a data derived from the Seouchogu Support center for Dementia of which included people aged 60 years or older in whom diagnosed with MCI using for consortium to establish a registry for Alzheimer's disease (CERAD) between 2012 and 2015. The longitudinal date of 702 MCI patients was used to investigate the relationships among
